Recent news on Visicol

Salix grows revenue, but profit shrinks on R&D costs  -  May 8, 2007
Triangle Business Journal,Colazal and travelers' diarrhea drug Xifaxan, jumped, as did sales of the company's bowel-cleansing drug line - Moviprep, Osmoprep and Visicol.

Salix Pharmaceuticals Announces 1Q2007 Financial Results ...  -  Apr 24, 2007
PharmaLive.com (press release),...sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for Oral Solution), VISICOL(R) Tablets (sodium phosphate monobasic monohydrate,

Salix Pharmaceuticals Licenses DIACOL(TM) to Dr. Falk Pharma in Europe  -  Apr 17, 2007
Genetic Engineering News (press release),...sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for Oral Solution), VISICOL(R) Tablets (sodium phosphate monobasic monohydrate,

Salix Pharmaceuticals to Present At CIBC World Markets Conference  -  Apr 4, 2007
Business Wire (press release),Salix markets COLAZAL ® , XIFAXAN ® , OSMOPREP™, VISICOL ® , MOVIPREP ® , PEPCID ® OS, DIURIL ® OS, AZASAN ® , ANUSOL-HC ® and PROCTOCORT ® .

Salix Pharmaceuticals Reports 4Q2006 and FY2006 Results  -  Feb 28, 2007
Business Wire (press release),VISICOL ® , OSMOPREP™ and MOVIPREP ® , combined, generated revenue of $11.5 million for the fourth quarter of 2006, and $45.5 million for the full year 2006

Salix Pharmaceuticals Acquires PEPCID(R) Oral Suspension  -  Mar 1, 2007
PipelineReview.com (press release),Salix markets COLAZAL®, XIFAXAN®, OSMOPREP™, MOVIPREP®, VISICOL®, AZASAN®, ANUSOL-HC® and PROCTOCORT®. Balsalazide tablets, Granulated Mesalamine,

Salix Pharmaceuticals Acquires Pepcid Oral Suspension  -  Feb 28, 2007
PharmaLive.com (press release),Salix markets COLAZAL(R), XIFAXAN(R), OSMOPREP(TM), MOVIPREP(R), VISICOL(R), AZASAN(R), ANUSOL-HC(R) and PROCTOCORT(R). Balsalazide tablets, Granulated

Salix Pharmaceuticals Acquires PEPCID ® Oral Suspension  -  Feb 28, 2007
Business Wire (press release),Salix markets COLAZAL ® , XIFAXAN ® , OSMOPREP™, MOVIPREP ® , VISICOL ® , AZASAN ® , ANUSOL-HC ® and PROCTOCORT ® . Balsalazide tablets, Granulated

Salix Pharmaceuticals to Present at Two Investment Conferences ...  -  Feb 22, 2007
PharmaLive.com (press release),Salix markets COLAZAL(R), XIFAXAN(R), OSMOPREP(TM), VISICOL(R), MOVIPREP(R) , AZASAN(R), ANUSOL-HC(R) and PROCTOCORT(R). Balsalazide tablets, Granulated

Salix Pharmaceuticals to Present at Two Investment Conferences ...  -  Feb 22, 2007
Business Wire (press release),Salix markets COLAZAL ® , XIFAXAN ® , OSMOPREP™, VISICOL ® , MOVIPREP ® , AZASAN ® , ANUSOL-HC ® and PROCTOCORT ® . Balsalazide tablets, Granulated

Salix Pharmaceuticals Announces 4Q2006 and FY2006 Financial ...  -  Feb 14, 2007
dBusinessNews Triangle (press release),Salix also markets XIFAXAN®, VISICOL®, OSMOPREP™, AZASAN®, ANUSOL-HC® and PROCTOCORT®. In August 2006, the FDA approved MOVIPREP® for bowel cleansing prior

Salix Pharmaceuticals Announces 4Q2006 and FY2006 Financial ...  -  Feb 14, 2007
PharmaLive.com (press release),Salix also markets XIFAXAN(R), VISICOL(R), OSMOPREP(TM), AZASAN(R), ANUSOL-HC(R) and PROCTOCORT(R). In August 2006, the FDA approved MOVIPREP(R) for bowel

Salix Pharmaceuticals Announces 4Q2006 and FY2006 Financial ...  -  Feb 14, 2007
Business Wire (press release),Salix also markets XIFAXAN ® , VISICOL ® , OSMOPREP™, AZASAN ® , ANUSOL-HC ® and PROCTOCORT ® . In August 2006, the FDA approved MOVIPREP ® for bowel

Colazal® Pediatric Indication Approved First 5-ASA Approved for ...  -  Dec 20, 2006
dBusinessNews Triangle (press release),Salix also markets XIFAXAN®, VISICOL®, OSMOPREP™, MOVIPREP®, AZASAN®, ANUSOL-HC® and PROCTOCORT®. Balsalazide tablets, Granulated Mesalamine, SANVAR® (600

Colazal(R) Pediatric Indication Approved  -  Dec 20, 2006
American Digital Networks (press release),Salix also markets XIFAXAN(R), VISICOL(R), OSMOPREP(TM), MOVIPREP(R), AZASAN(R), ANUSOL-HC(R) and PROCTOCORT(R). Balsalazide tablets, Granulated Mesalamine,

Colazal ® Pediatric Indication Approved  -  Dec 20, 2006
Business Wire (press release),Salix also markets XIFAXAN ® , VISICOL ® , OSMOPREP™, MOVIPREP ® , AZASAN ® , ANUSOL-HC ® and PROCTOCORT ® . Balsalazide tablets, Granulated Mesalamine,

Colazal® Pediatric Indication Approved First 5-ASA Approved for ...  -  Dec 20, 2006
dBusinessNews Triangle (press release),Salix also markets XIFAXAN®, VISICOL®, OSMOPREP™, MOVIPREP®, AZASAN®, ANUSOL-HC® and PROCTOCORT®. Balsalazide tablets, Granulated Mesalamine, SANVAR® (600

Colazal(R) Pediatric Indication Approved  -  Dec 20, 2006
American Digital Networks (press release),Salix also markets XIFAXAN(R), VISICOL(R), OSMOPREP(TM), MOVIPREP(R), AZASAN(R), ANUSOL-HC(R) and PROCTOCORT(R). Balsalazide tablets, Granulated Mesalamine,

Colazal ® Pediatric Indication Approved  -  Dec 20, 2006
Business Wire (press release),Salix also markets XIFAXAN ® , VISICOL ® , OSMOPREP™, MOVIPREP ® , AZASAN ® , ANUSOL-HC ® and PROCTOCORT ® . Balsalazide tablets, Granulated Mesalamine,

Salix Pharmaceuticals Reports 3Q2006 Results  Nov 7, 2006
Our bowel cleansing franchise, which in the third quarter was comprised of VISICOL(R), OSMOPREP(TM), and MOVIPREP(R), generated revenue of $6.6 million for the ... -Genetic Engineering News (press release), Salix Pharmaceuticals Reports American College of Gastroenterology ...  Oct 23, 2006
Twenty posters are being presented on XIFAXAN(R), two on COLAZAL(R), seven on OSMOPREP(TM), two on VISICOL(R) and one on our recently-approved MOVIPREP(R).". ... -Genetic Engineering News (press release), Salix Pharmaceuticals Reports American College of Gastroenterology ...  Oct 23, 2006
Twenty posters are being presented on XIFAXAN ® , two on COLAZAL ® , seven on OSMOPREP™, two on VISICOL ® and one on our recently-approved MOVIPREP ... -Business Wire (press release), Salix Pharmaceuticals Announces American College of ...  Oct 16, 2006
MD Solution plus Bisacodyl Polyp Detection Rate During Colonoscopy is L. Cohen, MD Oct 24 Correlated w/ Quality of Bowel Preparation Visicol Dehydration With ... -Genetic Engineering News (press release), Salix Pharmaceuticals Announces American College of ...  Oct 16, 2006
Salix markets Colazal ® (balsalazide disodium) Capsules 750 mg, Xifaxan ® (rifaximin) tablets 200 mg, Visicol ® Tablets (sodium phosphate monobasic ... -Business Wire (press release), Salix Pharmaceuticals Reports American College of Gastroenterology ...  Oct 23, 2006
Salix markets Colazal(R) (balsalazide disodium) Capsules 750 mg, Xifaxan(R) (rifaximin) tablets 200 mg, Visicol(R) Tablets (sodium phosphate monobasic ... -PharmaLive.com (press release), Salix Pharma Reports Results Of Trials Presented At American ...  Oct 23, 2006
Twenty posters are being presented on XIFAXAN®, two on COLAZAL®, seven on OSMOPREP(TM | charts | news | PowerRating), two on VISICOL® and one on our recently ... -Trading Markets, Salix Pharmaceuticals Announces 3Q2006 Financial Results ...  Oct 24, 2006
Salix also markets XIFAXAN(R), VISICOL(R), OSMOPREP(TM), AZASAN(R), ANUSOL-HC(R) and PROCTOCORT(R). In August 2006, the FDA approved MOVIPREP(R) for bowel ... -Genetic Engineering News (press release), Salix Pharmaceuticals Announces 3Q2006 Financial Results ...  Oct 24, 2006
...marketing team. Salix also markets XIFAXAN ® , VISICOL ® , OSMOPREP™, AZASAN ® , ANUSOL-HC ® and PROCTOCORT ® . In August ... -Business Wire (press release), Salix Pharmaceuticals to Present at Thomas Weisel Partners ...  Aug 30, 2006
Salix markets COLAZAL(R), XIFAXAN(R), VISICOL(R), OSMOPREP(TM), AZASAN(R), ANUSOL-HC(R) and PROCTOCORT(R). In August 2006, the FDA approved MOVIPREP(R) for ... -Genetic Engineering News

Debiopharm and Salix Pharmaceuticals sign license agreement for ...  Sep 5, 2006
Salix markets Colazal(R) (balsalazide disodium) Capsules 750 mg, Xifaxan(R) (rifaximin) tablets 200 mg, Visicol(R) Tablets (sodium phosphate monobasic ... -Canada NewsWire

Salix Pharmaceuticals and Debiopharm Sign SANVAR(R) License ...  Sep 6, 2006
Salix markets Colazal® (balsalazide disodium) Capsules 750 mg, Xifaxan® (rifaximin) tablets 200 mg, Visicol® Tablets (sodium phosphate monobasic monohydrate ... -PipelineReview.com

Salix Pharmaceuticals to Present at Piper Jaffray Health Care ...  -  Nov 22, 2006
PharmaLive.com (press release),Salix markets COLAZAL(R), XIFAXAN(R), OSMOPREP(TM), VISICOL(R), MOVIPREP(R) , AZASAN(R), ANUSOL-HC(R) and PROCTOCORT(R). Balsalazide tablets, Granulated

Salix Pharmaceuticals to Present at Piper Jaffray Health Care ...  -  Nov 22, 2006
Business Wire (press release),Salix markets COLAZAL ® , XIFAXAN ® , OSMOPREP™, VISICOL ® , MOVIPREP ® , AZASAN ® , ANUSOL-HC ® and PROCTOCORT ® . Balsalazide tablets, Granulated

Salix Pharmaceuticals to Present at Piper Jaffray Health Care ...  -  Nov 23, 2006
dBusinessNews Charlotte (press release),Salix markets COLAZAL®, XIFAXAN®, OSMOPREP™, VISICOL®, MOVIPREP® , AZASAN®, ANUSOL-HC® and PROCTOCORT®. Balsalazide tablets, Granulated Mesalamine,

USFDA grants Salix Pharmaceuticals marketing exclusivity for ...  29 Aug 2006
Salix also markets XIFAXAN(R), VISICOL(R), OSMOPREP(TM), AZASAN(R), ANUSOL-HC(R) and PROCTOCORT(R). In August 2006, the FDA approved MOVIPREP(R) for bowel ... -Carolina Newswire

Salix Pharmaceuticals Reports 2Q2006 Results  Aug 8, 2006
Our bowel cleansing franchise, which in the second quarter was comprised of two marketed products, VISICOL(R) and the newly-approved OSMOPREP(TM), generated ... -Business Wire

Salix Pharmaceuticals to Present at Bank of America Conference  Aug 8, 2006
Salix markets COLAZAL(R), XIFAXAN(R), VISICOL(R), OSMOPREP(TM), MOVIPREP(R), AZASAN(R), ANUSOL-HC(R) and PROCTOCORT(R). Granulated mesalamine is under ... -Business Wire

MoviPrep(R) Granted FDA Marketing Approval; New Two-Liter Liquid ...  Aug 2, 2006
Salix also markets Colazal(R) (balsalazide disodium) Capsules 750 mg, Xifaxan(R) (rifaximin) tablets 200 mg, Visicol(R) Tablets (sodium phosphate monobasic ... -Genetic Engineering News

MOVIPREP(R) Granted FDA Marketing Approval  Aug 3, 2006
Salix also markets Colazal® (balsalazide disodium) Capsules 750 mg, Xifaxan® (rifaximin) tablets 200 mg, Visicol® Tablets (sodium phosphate monobasic ... -PipelineReview.com

Salix Expands XIFAXAN Intellectual Property  Jul 6, 2006
Salix also markets COLAZAL, VISICOL Tablets, OSMOPREP Tablets, AZASAN, Anusol-HC 2.5%, Anusol-HC 25 mg Suppository, Proctocort Cream 1% and Proctocort ... -ag-IP-news Agency

Salix Expands XIFAXAN(R) Intellectual Property; Secures License ...  Jul 5, 2006
Salix also markets COLAZAL(R), VISICOL(R) Tablets, OSMOPREP(TM) Tablets, AZASAN(R), Anusol-HC(R) 2.5%, Anusol-HC(R) 25 mg Suppository, Proctocort(R) Cream 1 ... -Genetic Engineering News



Salix Pharmaceuticals Reports 1Q2006 Results  May 4, 2006
VISICOL(R) generated revenue of $9.8 million for the first quarter of 2006, compared to $5.2 million a year ago when InKine was independent. ... - Genetic Engineering News

FDA CAPSULES  May 16, 2006
Documented cases include patients who used a solution (such as Fleet Phospho-soda or Fleet Accu-Prep) or tablets (Visicol). NEW DRUG FOR BONE MARROW DISORDER. ... - Newsday

Oral Sodium Phosphate (OSP) Products for Bowel Cleansing  May 9, 2006
...has been associated with the use of oral sodium phosphate (OSP) products (eg, Fleet Phospho-soda solution, Fleet Accu-Prep solution, and Visicol tablets) for ... - Food Consumer

Non-liquid colonoscopy prep approved  Apr 25, 2006
Last year Salix Pharmaceuticals bought out Inkine Pharmaceuticals, which has produced a bowel cleansing prescription tablet, known as Visicol, for six years. ... - Newsday

Bowel Cleansers Get FDA Warning  May 5, 2006
Of the cases, 21 involved patients given solutions such as Fleet Phospho-soda or Fleet Accu-Prep. One patient had taken Visicol tablets. ... - Los Angeles Times

Salix Q1 EPS Rises On Surged Revenues, Yet Misses Estimates ...  May 4, 2006
...prior-year quarter. Revenues from VISICOL rose to $9.8 million from $5.2 million in the last year's quarter. The company forecasts ... - Trading Markets

FDA alert focuses on bowel cleansers  May 5, 2006
One patient had taken Visicol tablets. The FDA says none of the cases involved a recently approved product called OsmoPrep tablets. - KTRE

FDA Issues Warning on Bowel-Cleansing Products  May 5, 2006
Twenty-one of the cases involved patients given products such as Fleet Phospho-soda or Fleet Accu-Prep. One patient had taken Visicol tablets. ... - KPHO Phoenix

Salix Pharmaceuticals Announces 1Q2006 Financial Results ...  Apr 20, 2006
Salix markets COLAZAL(R), XIFAXAN(R), VISICOL(R), OSMOPREP(TM), AZASAN(R), ANUSOL-HC(R) and PROCTOCORT(R). MOVIPREP(R) and granulated mesalamine are under ... - Genetic Engineering News

Salix Announces Completion of OsmoPrep(TM) versus Liquid Bowel ...  Apr 19, 2006
Salix also markets COLAZAL(R) (balsalazide disodium) Capsules 750 mg, XIFAXAN(R) (rifaximin) tablets 200 mg, VISICOL(R) Tablets (sodium phosphate monobasic ... - Genetic Engineering News





Bowel-cleansing products, kidney failure are linked  Mar 15, 2006
Common bowel-cleansing drugs that include sodium phosphate are Visicol, a prescription oral tablet, and the non-prescription product Fleet Phospho-soda. ... - Biloxi Sun Herald

Salix Pharmaceuticals to Present at Four Investment Conferences ...  Mar 28, 2006
Salix markets COLAZAL(R), XIFAXAN(R), VISICOL(R), OSMOPREP(TM), AZASAN(R), ANUSOL-HC(R) and PROCTOCORT(R). Granulated mesalamine and NRL944 are under ... - Genetic Engineering News

OsmoPrep(TM) Tablets Granted FDA Marketing Approval; New Tablet ...  Mar 17, 2006
Salix also markets COLAZAL(R) (balsalazide disodium) Capsules 750mg, XIFAXAN(R) (rifaximin) tablets 200 mg, VISICOL(R) Tablets (sodiumphosphate monobasic ... - Finanzen.net

Health Highlights: March 8, 2006  Mar 8, 2006
Common bowel-cleansing drugs that contain sodium phosphate include the prescription oral tablet Visicol and the non-prescription product Fleet Phospho-soda ... - Forbes

Bowel-Cleansing Products Linked To Kidney Failure  Mar 7, 2006
Bowel-cleansing drugs that contain sodium phosphate include prescription Visicol and the non-prescription product Fleet Phospho-soda. - All Headline News



Long courtship ends with vows for Salix  Feb 20, 2006
Blue Bell, Pa.-based InKine's only approved drug was Visicol, a patent-protected drug that cleans the bowels in preparation for a colonoscopy. ... - Raleigh Triangle Business Journal,

Salix Pharmaceuticals to Present at Roth Capital Conference  Feb 14, 2006
Salix markets COLAZAL(R), XIFAXAN(R), VISICOL(R), AZASAN(R), ANUSOL-HC(R) and PROCTOCORT(R). Granulated mesalamine, INKP-102 and NRL944 are under development. ... - Genetic Engineering News,

Are there risks to colonoscopy prep procedures?  Feb 5, 2006
...only prep. The patient takes 28 to 32 pills of Visicol, but this carries the some risks and may not yield a clean enough colon. - Boston Globe,

Are there risks to colonoscopy prep procedures?  Feb 5, 2006
...only prep. The patient takes 28 to 32 pills of Visicol, but this carries the some risks and may not yield a clean enough colon. - Boston Globe

Does it cause renal problems?  Jan 9, 2006
The products are oral preparations made with sodium phosphate and they include Visicol tablets and over-the-counter solutions like Fleet-Phosphosoda and store ... - Deccan Herald

Salix Pharmaceuticals Announces 4Q2005 and FY2005 Financial ...  Jan 31, 2006
Salix markets COLAZAL(R), XIFAXAN(R), VISICOL(R), AZASAN(R), ANUSOL-HC(R) and PROCTOCORT(R). Granulated mesalamine, INKP-102 and NRL944 are under development. ... - Genetic Engineering News

Salix Pharmaceuticals Development Update; XIFAXAN(R) Trials ...  Jan 11, 2006
...placebo. Salix also markets VISICOL(R) Tablets (sodium phosphate monobasic monohydrate, USP, sodium phosphate dibasic anhydrous, USP). ... - Business Wire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional